Iovance Biotherapeutics, Inc. (IOVA)
NASDAQ: IOVA · Real-Time Price · USD
8.09
-0.35 (-4.21%)
Aug 26, 2026, 4:00 PM EDT - Market closed
Iovance Biotherapeutics Stock Forecast
Stock Price Forecast
According to 9 analysts polled by S&P Global, Iovance Biotherapeutics stock has a consensus rating of "Buy" and an average price target of $10. The average 1-year stock price forecast is 23.69% higher than the current stock price, while the lowest is $6.00 (-25.79%) and the highest is $14 (+73.16%).
Price Target: $10 (+23.69%)
Analyst Consensus: Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for Iovance Biotherapeutics stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Mar '26 | Apr '26 | May '26 | Jun '26 | Jul '26 | Aug '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 6 | 6 | 6 | 6 | 5 | 5 |
| Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Hold | 3 | 3 | 2 | 2 | 2 | 2 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 11 | 11 | 10 | 10 | 9 | 9 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| TD Cowen | TD Cowen | Buy Reiterates $7 → $10 | Buy | Reiterates | $7 → $10 | +23.69% | Aug 25, 2026 |
| UBS | UBS | Hold Reiterates $4 → $7 | Hold | Reiterates | $4 → $7 | -13.42% | Aug 20, 2026 |
| Mizuho Securities | Mizuho Securities | Buy Maintains $10 → $11 | Buy | Maintains | $10 → $11 | +36.05% | Aug 17, 2026 |
| Robert W. Baird | Robert W. Baird | Hold Maintains $4 → $6 | Hold | Maintains | $4 → $6 | -25.79% | Aug 7, 2026 |
| Citizens JMP | Citizens JMP | Buy Maintains $5 → $8 | Buy | Maintains | $5 → $8 | -1.05% | Aug 7, 2026 |
Financial Forecast
Revenue This Year
412.17M
from 263.50M
Increased by 56.42%
Revenue Next Year
569.31M
from 412.17M
Increased by 38.13%
EPS This Year
-0.48
from -1.09
EPS Next Year
-0.27
from -0.48
EPS and Forward PE are based on non-GAAP adjusted numbers.